Lab Equipment4 min read

What it took to clean six grapevine varieties of eight viruses

A Slovenian-French program combined heat treatment, meristem micrografting and RT-PCR testing on preclonal grapevine candidates. Its numbers show what clean-stock production can cost in losses and time, and what a paper cannot tell you about equipment.

By xPlant EditorialUpdated 2026-11-16
RedditLinkedIn
Illustration of a toy-like character with a green cap-shaped top and a white lab coat, wearing yellow gloves and lifting a small grapevine plantlet from a glass jar of pale gel at a green bench, with a second plantlet in a yellow tray and a clipboard showing a line graph beside it.
A toy character examines a grapevine plantlet in a gel vessel during virus-clean stock work.Illustration: xPlant Pro.

Field notes

  • In one grapevine study, in vivo thermotherapy at 36–38 °C for at least six weeks, followed by 0.1–0.2 mm meristem tip micrografting, was paired with RT-PCR testing.
  • Regeneration was low: 598 meristems gave 51 plants, with variety rates from 3.3% (Pokalca) to 16.7% (Rebula).
  • All eight viruses tested were eliminated in the regenerated plants, but viroid-free rates were only 39.2% (HSVd) and 42.6% (GYSVd-1).
  • The paper gives no equipment makes, capacities or costs, so it cannot price a build-out.

The decision behind clean stock

If you propagate or buy a crop where viruses matter, the real question is what a tested mother plant costs to produce. A grapevine program from Slovenia and France, published in Plants (MDPI) and archived on PubMed Central, answers it for one crop. It is a single study of six varieties, and its results belong to those genotypes and that protocol, not to every lab.

The authors' starting point is blunt. Viruses cannot be controlled by standard plant protection measures, and "once infected, plants remain infected throughout their life." That is why they treat planting healthy vegetative material as crucial.

Protocol

The steps, as the paper reports them

The work started with preclonal candidates of six Vitis vinifera varieties: Laški rizling, Rebula, Zeleni Sauvignon, Malvazija, Refošk and Pokalca. This paper tracks eight of those viruses and both viroids.

Thermotherapy: in vivo, at 36–38 °C for at least six weeks.

Micrografting: meristem tips of 0.1–0.2 mm placed onto in vitro-growing seedling rootstocks of Vialla (Vitis labrusca × Vitis riparia).

Medium: half-strength MS with vitamins, 30 g/L sucrose and 8 g/L agar, with no plant growth regulators. It was used for the micrografts and the later micropropagated plants. The authors saw no callus formation, hyperhydricity or necrosis of shoot tips.

Testing: RT-PCR on regenerated plants after seven months in vitro. Positive controls gave the expected products and negative controls gave none.

Acclimation: rockwool plugs, then a mini greenhouse inside a growth chamber, then pots. The abstract says the plants were later transferred to soil.

The authors also note a tradeoff in meristem size. Smaller meristems survive less often but eliminate virus most efficiently.

What the study reports

There are no grower anecdotes here, only a peer-reviewed dataset, so these are the study's figures and no one else's.

The authors call overall regeneration low, and higher in white varieties than red. The text available here does not give the Malvazija or Refošk rates in prose. Individual candidates varied widely: one Laški rizling sample (3/45B), infected with eight viral entities, produced no plants, and neither did two Refošk samples or one Pokalca sample.

The authors add that Rebula regenerated best, but Zeleni Sauvignon grew much faster during micropropagation.

On testing, the regenerated plants showed 100% elimination of all eight viruses. The authors say the virus-free candidates will be retested. These figures describe plants that regenerated and were tested, not all 598 meristems.

Buyer

Testing is a rule in this market

Check which tests apply where you sell, and ask what method and date sit behind any "clean" claim. A clean result is an observation from a particular test on a particular date.

What a paper cannot tell you about equipment

This is where a lab-build budget runs into limits. The text available here names a growth chamber, a mini greenhouse and rockwool plugs. It gives no make, capacity, wattage or cost for the thermotherapy setup or the chamber, and no labor hours per micrograft. You can copy the temperature window and the medium from the paper, but not the running costs of the heat treatment or the space it takes.

The call

Read this paper as a map of the stages and an honest picture of attrition, not as a recipe that transfers. If you are costing a clean-stock program for grapevine, plan for steep losses at micrografting (3.3% to 16.7% by variety in this study). Plan for a long wait, since testing here came after seven months in vitro. And plan for testing that can answer differently by pathogen, because viroids behaved nothing like viruses in this dataset.

For another crop or another genotype, treat the 36–38 °C window and the 0.1–0.2 mm meristem size as starting points to check against crop-specific literature. Nothing in the paper says they carry over. Before you invest in chambers, price the testing and the rate of loss, because the paper gives you no equipment figures to lean on.

From the bench to the books

Run the lab on records, not memory

Sources

References and credits

  1. Elimination of Eight Viruses and Two Viroids from Preclonal Candidates of Six Grapevine Varieties (Vitis vinifera L.) through In Vivo Thermotherapy and In Vitro Meristem Tip MicrograftingOfficial source · Plants (MDPI), via PubMed Central · Peer-reviewed, open access (CC BY). Text read to its first 12,000 characters; figures and supplementary material not reviewed.
RedditLinkedIn